Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 10, 2026 · Leadership change · Charter amendment · Item 5.07 · +1 more
Sensei Biotherapeutics, Inc.
9
Leadership change
Jun 10, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.03 | Amended articles of incorporation or bylaws |
| Item 5.07 | Item 5.07 |
| Item 9.01 | Financial statements and exhibits |
Sensei Biotherapeutics, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
) 1405 Research Blvd , Suite 125 Rockville , MD 20850 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 240 ) 243-8000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Sensei Biotherapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
